AxoGen and LifeNet Health Partner to Expand Treatment Options for Patients with Peripheral Nerve Injuries
ALACHUA, Fla. (Business Wire EON/PRWEB ) March 17, 2008 --
AxoGen Nerve Regeneration announces a strategic partnership with LifeNet
Health, a leading allograft bio-implant company, for the processing of
Avance Nerve Grafts. Launched in 2007, Avance Nerve Graft is the only
off-the-shelf product available that gives surgeons the option to repair
damaged peripheral nerves with human allograft nerve. Peripheral nerves
enable communication between the brain and muscles or senses. Avance
Nerve Graft allows surgeons to perform the typically preferred
nerve-to-nerve repair while eliminating the need for a second donor site
surgery. “We are proud to partner with LifeNet Health
in providing donor families another option for tissue donation. With
this partnership, we will be able to reach even more patients in need of
peripheral nerve repair to improve and restore their quality of life,”
states Karen Zaderej, COO for AxoGen. “The clinical benefit this technology brings
to patients is tremendous, LifeNet Health is excited to help AxoGen
bring this treatment option to more patients, helping us to fulfill our
mission of saving lives, and restoring health,”
states Doug Wilson, Executive Vice President for LifeNet Health. About LifeNet LifeNet Health, founded in 1982, is a full service biomedical tissue
banking system and a leading non-profit organ and tissue donation agency
whose mission is saving lives and restoring health. LifeNet Health
provides recovery services for musculoskeletal and cardiovascular
tissue, distributing more than 250,000 biomedical implants every year to
restore health to patients around the world. About AxoGen Based in Alachua, Florida, AxoGen is committed to supporting surgeons in
improving the standard of care for patients with peripheral nerve
injuries by “Bringing the Science of Nerve
Repair to Life.” The company is privately held
and has received funding from Accuitive Medical Ventures, Cardinal
Partners, De Novo Ventures, Springboard Capital II, LLC, SynoGen, and
Emergent Growth Fund of Gainesville, FL. Visit AxoGen at: www.axogeninc.com.
|
